These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36235612)

  • 21. Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.
    Khedr EM; Omeran N; Karam-Allah Ramadan H; Ahmed GK; Abdelwarith AM
    J Alzheimers Dis; 2022; 88(3):1103-1114. PubMed ID: 35754271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-altitude Tibetan fermented milk ameliorated cognitive dysfunction by modified gut microbiota in Alzheimer's disease transgenic mice.
    Liu J; Yu C; Li R; Liu K; Jin G; Ge R; Tang F; Cui S
    Food Funct; 2020 Jun; 11(6):5308-5319. PubMed ID: 32458851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    Jemimah S; Chabib CMM; Hadjileontiadis L; AlShehhi A
    PLoS One; 2023; 18(5):e0285346. PubMed ID: 37224131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of the Gut Microbiota in Memory Impairment and Alzheimer's Disease via the Inhibition of the Parasympathetic Nervous System.
    Park S; Wu X
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of acupuncture therapy in the treatment of MCI patients with the ApoE ε4 gene based on the brain-gut axis theory.
    Jin Y; Chen J; Chai Q; Zhu J; Jin X
    BMC Complement Med Ther; 2023 Jul; 23(1):227. PubMed ID: 37422636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice.
    Maldonado Weng J; Parikh I; Naqib A; York J; Green SJ; Estus S; LaDu MJ
    Mol Neurodegener; 2019 Dec; 14(1):47. PubMed ID: 31861986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiome alterations in preclinical Alzheimer's disease.
    Jung JH; Kim G; Byun MS; Lee JH; Yi D; Park H; Lee DY;
    PLoS One; 2022; 17(11):e0278276. PubMed ID: 36445883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of
    Ueda A; Shinkai S; Shiroma H; Taniguchi Y; Tsuchida S; Kariya T; Kawahara T; Kobayashi Y; Kohda N; Ushida K; Kitamura A; Yamada T
    Cell Rep Med; 2021 Sep; 2(9):100398. PubMed ID: 34622235
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Tran TTT; Corsini S; Kellingray L; Hegarty C; Le Gall G; Narbad A; Müller M; Tejera N; O'Toole PW; Minihane AM; Vauzour D
    FASEB J; 2019 Jul; 33(7):8221-8231. PubMed ID: 30958695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the gut microbiome of obese, African American, older adults with and without mild cognitive impairment.
    McLeod A; Penalver Bernabe B; Xia Y; Sanchez-Flack J; Lamar M; Schiffer L; Castellanos K; Fantuzzi G; Maki P; Fitzgibbon M; Tussing-Humphreys L
    PLoS One; 2023; 18(2):e0280211. PubMed ID: 36827280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Gut Microbiome for Conversion from Mild Cognitive Impairment to Alzheimer's Disease Dementia within 4 Years: Results from the AlzBiom Study.
    Laske C; Müller S; Munk MHJ; Honold I; Willmann M; Peter S; Schoppmeier U
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered gut microbiota in older adults with mild cognitive impairment: a case-control study.
    Fan KC; Lin CC; Liu YC; Chao YP; Lai YJ; Chiu YL; Chuang YF
    Front Aging Neurosci; 2023; 15():1162057. PubMed ID: 37346147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of Alzheimer's disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients.
    Zhang Y; Shen Y; Liufu N; Liu L; Li W; Shi Z; Zheng H; Mei X; Chen CY; Jiang Z; Abtahi S; Dong Y; Liang F; Shi Y; Cheng LL; Yang G; Kang JX; Wilkinson JE; Xie Z
    Mol Psychiatry; 2023 Oct; 28(10):4421-4437. PubMed ID: 37604976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Shanghai Aging Study.
    Xi J; Ding D; Zhao Q; Liang X; Zheng L; Guo Q; Hong Z; Fu H; Xu J; Xiao Q
    Curr Alzheimer Res; 2020; 17(2):185-195. PubMed ID: 32183673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
    Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
    Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.